FibroBiologics, Inc. Common StockFBLGNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank93
3Y CAGR+191.4%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
+191.4%/yr
Quarterly compound
Percentile
P93
Near historical high
vs 3Y Ago
24.7x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 202562.46%
Q3 2025-8.33%
Q2 202514.29%
Q1 2025-57.13%
Q4 2024-791.00%
Q3 2024-133.33%
Q2 2024111.11%
Q1 202412.90%
Q4 2023-359.26%
Q3 2023-1.50%
Q2 202355.67%
Q1 2023-198.80%
Q4 20222.52%
Q3 2022-43.06%
Q2 20220.00%
Q1 20220.00%